{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-044824","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.069382+00:00","generated_at":"2026-05-21T03:35:31.859830+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PMGC subsidiary Northstrive signs binding term sheet with Modulant for exclusive animal health license of EL-22","bullets":["Northstrive grants Modulant exclusive global rights (ex-Korea) to develop/commercialize EL-22 as a probiotic for livestock muscle preservation.","EL-22 targets the myostatin pathway via modified lactobacillus casei; Modulant is led by former Elanco executive Tom Campi.","Modulant will pay Northstrive a share of all sublicensing and commercial revenues, with a royalty rate that decreases after a dollar limit.","Definitive license agreement expected in coming months, subject to approval from Northstrive's head licensor for certain IP rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-044824","json":"https://secwatch.observer/filing/0001213900-25-044824.json","markdown":"https://secwatch.observer/filing/0001213900-25-044824.md","text":"https://secwatch.observer/filing/0001213900-25-044824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025044824/0001213900-25-044824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025044824/ea0241550-8k_pmgc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:35:31.859830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}